MentionFox
Home › Executive changes › Lemaitre Vascular Inc
Leadership changes · SEC Form 8-K, Item 5.02

Lemaitre Vascular Inc executive changes

Every leadership change Lemaitre Vascular Inc reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings1
Departures named2
Latest filing2026-04-14

Lemaitre Vascular Inc filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-04-14. Between them they name 2 people. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-04-14 · 8-K

Departing: Bridget Ross, Director

(b) On April 8, 2026, Bridget Ross notified the Board of Directors (the "Board") of LeMaitre Vascular, Inc. (the "Company") of her intent not to stand for re-election as a Class II director of the Company at the Company's 2026 Annual Meeting of Stockholders to be held on June 2, 2026 (the "2026 Annual Meeting").

Departing: David B. Roberts, Director

In connection with such nomination, on April 9, 2026, Mr. Roberts notified the Board of his intent to resign as a Class I director at the conclusion of the 2026 Annual Meeting, contingent upon his election as a Class II director at such meeting.
Hiring for a seat like this?

Find people with the same kind of experience as the Director at Lemaitre Vascular Inc, with the record behind each one.

Find candidates like Director at Lemaitre Vascular Inc
Selling to Lemaitre Vascular Inc?

New leaders review vendors and budgets in their first months. Get an alert the next time Lemaitre Vascular Inc is in the news or changes leadership.

Get an alert when Lemaitre Vascular Inc changes leadership

Tools for this story

Each opens in a new tab, filled in for Lemaitre Vascular Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/lemaitre-vascular
Last updated 2026-09-27
Primary record: SEC filing
Lemaitre Vascular Inc (LMAT) executive changes: Bridget Ross departs, Director. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/lemaitre-vascular